Short report: Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital chagas disease

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 5, 2010, Pages 1044-1047

  Brutus, Laurent ^a,b   Castillo, Helen ^c   Bernal, Claudia ^c   Salas, Nadin Alejandra ^c   Schneider, Dominique ^a,b   Santalla, José Antonio ^d   Chippaux, Jean Philippe ^a,b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Institut de recherche pour le developpement Bolivia   (Bolivia)

^d Instituto Nacional de Laboratorios de Salud Bolivia   (Bolivia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADOLESCENT; ADULT; ARTICLE; ATTENTION; BIRTH; BLOOD; BLOOD EXAMINATION; BOLIVIA; CHAGAS DISEASE; CONGENITAL INFECTION; CORRELATION ANALYSIS; DELIVERY; FEMALE; HEMATOCRIT; HUMAN; INFECTION RISK; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MICROSCOPY; MOTHER; NEWBORN PERIOD; NONHUMAN; PARASITEMIA; PREGNANCY; PREMATURITY; PREVALENCE; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SEROLOGY; SOUTH AND CENTRAL AMERICA; THIRD TRIMESTER PREGNANCY; TRYPANOSOMA CRUZI; VECTOR CONTROL; DISEASE TRANSMISSION; MIDDLE AGED; NEWBORN; PREGNANCY COMPLICATION; VERTICAL TRANSMISSION;

TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; BOLIVIA; CHAGAS DISEASE; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LONGITUDINAL STUDIES; MIDDLE AGED; PARASITEMIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 79952062805     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0326     Document Type: Article

References (19)

1. Schofield CJ, Jannin J, Salvatella R, 2006. The future of Chagas disease control. Trends Parasitol 22: 583-588. (Pubitemid 44781088)
2. Torrico MC, Solano M, Guzmán JM, Parrado R, Suarez E, Alonzo-Vega C, Truyens C, Carlier Y, Torrico F, 2005. Estimation of the parasitemia in Trypanosoma cruzi human infection: high parasitemias are associated with severe and fatal congenital Chagas disease [in Portuguese]. Rev Soc Bras Med Trop 38 (Suppl 2): 58-61.
3. Salas NA, Cot M, Schneider D, Mendoza B, Santalla JA, Postigo J, Chippaux JP, Brutus L, 2007. Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia. Trop Med Int Health 12: 1498-1505. (Pubitemid 350212717)
4. Carlier Y, 2005. Factors and mechanisms involved in the transmission and development of congenital infection with Trypanosoma cruzi [in Portuguese]. Rev Soc Bras Med Trop 38 (Suppl 2): 105-107.
5. Hermann E, Truyens C, Alonso-Vega C, Rodriguez P, Berthe A, Torrico F, Carlier Y, 2004. Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon-gamma in response to parasite antigens. J Infect Dis 189: 1274-1281. (Pubitemid 38457253)
6. Bern C, Verastegui M, Gilman RH, Lafuente C, Galdos-Cardenas G, Calderon M, Pacori J, Del Carmen Abastoflor M, Aparicio H, Brady MF, Ferrufino L, Angulo N, Marcus S, Sterling C, Maguire JH, 2009. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis 49: 1667-1674.
7. Freilij H, Muller L, Gonzalez Cappa SM, 1983. Direct micromethod for diagnosis of acute and congenital Chagas' disease. J Clin Microbiol 18: 327-330. (Pubitemid 13076295)
8. Portela-Lindoso AA, Shikanai-Yasuda MA, 2003. Chronic Chagas' disease: from xenodiagnosis and hemoculture to polymerase chain reaction [in Spanish]. Rev Saude Publica 37: 107-115. (Pubitemid 36181485)
9. Storni P, Bolsi FL, 1979. Pregnancy and Trypanosoma cruzi parasitism [in Spanish]. Medicina (B Aires) 39: 193-197.
10. Menezes CA, Bittencourt AL, Mota E, Sherlock I, Ferreira J, 1992. The assessment of parasitemia in women who are carriers of Trypanosoma cruzi infection during and after pregnancy [in Portuguese]. Rev Soc Bras Med Trop 25: 109-113.
11. Torrico F, Vega CA, Suarez E, Tellez T, Brutus L, Rodriguez P, Torrico MC, Schneider D, Truyens C, Carlier Y, 2006. Are maternal re-infections with Trypanosoma cruzi associated with higher morbidity and mortality of congenital Chagas disease? Trop Med Int Health 11: 628-635.
12. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ, 1996. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 275: 599-605. (Pubitemid 26062797)
13. Desmonts G, Couvreur J, 1974. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull NY Acad Med 50: 146-159.
14. Vekemans J, Truyens C, Torrico F, Solano M, Torrico MC, Rodriguez P, Alonso-Vega C, Carlier Y, 2000. Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells to produce pro- and anti-inflammatory cytokines. Infect Immun 68: 5430-5434.
15. Truyens C, Hermann E, Alonso-Vega C, Rodriguez P, Vekemans J, Torrico F, Carlier Y, 2005. Immune responses of non-infected neonates of mothers infected with Trypanosoma cruzi [in Portuguese]. Rev Soc Bras Med Trop 38 (Suppl 2): 96-100.
16. Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, Candia N, Calcena MF, Figueredo A, 1998. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 59: 487-491. (Pubitemid 28429096)
17. Blanco SB, Segura EL, Cura EN, Chuit R, Tulian L, Flores I, Garbarino G, Villalonga JF, Gürtler RE, 2000. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health 5: 293-301. (Pubitemid 30316804)
18. Anonymous, 1987. Essential drugs. Trypanosomiases. WHO Drug Information 1: 230-237.
19. Anonymous, 2009. Antitrypanosomal medicines. Stuart MC, Kouimtzi M, Hill SR, eds. American Trypanosomiasis. WHO Model Formulary 2008. Geneva: World Health Organization, 211-213.